Psagot Value Holdings’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Psagot Value Holdings's BMY Position: Q2 2024 in Review
Psagot Value Holdings sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 3,398 shares — an estimated $184K sold.
Psagot Value Holdings first reported a position in BMY in Q2 2019 and held it in 19 quarters. The position peaked at $5.55M in Q4 2022. 2,152 funds tracked by Wall St. Rank hold BMY as of Q2 2024.
- Psagot Value Holdings reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
- Psagot Value Holdings sold 3,398 Bristol-Myers Squibb shares in Q2 2024, an estimated $184K.
- Psagot Value Holdings first reported a position in Bristol-Myers Squibb in Q2 2019 and held it in 19 quarters.
- Psagot Value Holdings's Bristol-Myers Squibb position peaked at $5.55M in Q4 2022.
- 2,152 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.
Based on Psagot Value Holdings's 13F filing for Q2 2024.